Stay updated on DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma
Sign up to get notified when there's something new on the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page.

Latest updates to the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page
- Check7 days agoChange DetectedAdded navigation and help sections such as 'Last verified', 'Last known status was', 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', plus related topic links (Intervention/Treatment, Multiple myeloma, MedlinePlus Genetics) and updated the revision tag to v3.6.0. Removed older labels including 'Verified', 'Last known status was:', 'Intervention / Treatment', and 'Revision: v3.5.5'.SummaryDifference2%

- Check14 days agoChange DetectedThe page footer revision tag was updated from v3.5.4 to v3.5.5, indicating a maintenance version of the record.SummaryDifference0.1%

- Check21 days agoChange DetectedThe page’s disease label and a related topics section linking to MedlinePlus Genetics were removed, reducing visibility of the condition being studied and access to related resources.SummaryDifference0.2%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedA new revision label v3.5.4 was added and the previous label v3.5.3 was removed. This update reflects an adjustment to the page's version information.SummaryDifference0.1%

- Check57 days agoChange DetectedThe ClinicalTrials.gov page’s displayed revision/version tag has been incremented from v3.5.2 to v3.5.3, indicating a site update rather than a change to the underlying study information.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded Revision: v3.5.2; removed entries for Multiple myeloma, related topics, MedlinePlus Genetics, and Revision: v3.5.0.SummaryDifference0.2%

Stay in the know with updates to DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma
Enter your email address, and we'll notify you when there's something new on the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page.